161 related articles for article (PubMed ID: 23992292)
1. Towards the rational design of antimicrobial proteins: single point mutations can switch on bactericidal and agglutinating activities on the RNase A superfamily lineage.
Pulido D; Moussaoui M; Nogués MV; Torrent M; Boix E
FEBS J; 2013 Nov; 280(22):5841-52. PubMed ID: 23992292
[TBL] [Abstract][Full Text] [Related]
2. An insertion in loop L7 of human eosinophil-derived neurotoxin is crucial for its antiviral activity.
Sikriwal D; Seth D; Parveen S; Malik A; Broor S; Batra JK
J Cell Biochem; 2012 Oct; 113(10):3104-12. PubMed ID: 22581709
[TBL] [Abstract][Full Text] [Related]
3. Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage.
Sánchez D; Moussaoui M; Carreras E; Torrent M; Nogués V; Boix E
Biochimie; 2011 Feb; 93(2):331-8. PubMed ID: 20951760
[TBL] [Abstract][Full Text] [Related]
4. Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall.
Torrent M; Badia M; Moussaoui M; Sanchez D; Nogués MV; Boix E
FEBS J; 2010 Apr; 277(7):1713-25. PubMed ID: 20180804
[TBL] [Abstract][Full Text] [Related]
5. Structural determinants of the eosinophil cationic protein antimicrobial activity.
Boix E; Salazar VA; Torrent M; Pulido D; Nogués MV; Moussaoui M
Biol Chem; 2012 Aug; 393(8):801-15. PubMed ID: 22944682
[TBL] [Abstract][Full Text] [Related]
6. Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein.
Carreras E; Boix E; Rosenberg HF; Cuchillo CM; Nogués MV
Biochemistry; 2003 Jun; 42(22):6636-44. PubMed ID: 12779318
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment.
Torrent M; de la Torre BG; Nogués VM; Andreu D; Boix E
Biochem J; 2009 Jul; 421(3):425-34. PubMed ID: 19450231
[TBL] [Abstract][Full Text] [Related]
8. A novel cationic ribonuclease with antimicrobial activity from Rana dybowskii.
Tao F; Fan M; Zhao W; Lin Q; Ma R
Biochem Genet; 2011 Jun; 49(5-6):369-84. PubMed ID: 21259045
[TBL] [Abstract][Full Text] [Related]
9. Refining the eosinophil cationic protein antibacterial pharmacophore by rational structure minimization.
Torrent M; Pulido D; de la Torre BG; García-Mayoral MF; Nogués MV; Bruix M; Andreu D; Boix E
J Med Chem; 2011 Jul; 54(14):5237-44. PubMed ID: 21696142
[TBL] [Abstract][Full Text] [Related]
10. Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein.
Singh A; Batra JK
Biol Chem; 2011 Apr; 392(4):337-46. PubMed ID: 21303303
[TBL] [Abstract][Full Text] [Related]
11. Eosinophil cationic protein aggregation: identification of an N-terminus amyloid prone region.
Torrent M; Odorizzi F; Nogués MV; Boix E
Biomacromolecules; 2010 Aug; 11(8):1983-90. PubMed ID: 20690710
[TBL] [Abstract][Full Text] [Related]
12. Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site.
Torrent M; Nogués MV; Boix E
J Mol Recognit; 2011; 24(1):90-100. PubMed ID: 20213669
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases.
Barker RL; Loegering DA; Ten RM; Hamann KJ; Pease LR; Gleich GJ
J Immunol; 1989 Aug; 143(3):952-5. PubMed ID: 2745977
[TBL] [Abstract][Full Text] [Related]
14. Evolution of antiviral activity in the ribonuclease A gene superfamily: evidence for a specific interaction between eosinophil-derived neurotoxin (EDN/RNase 2) and respiratory syncytial virus.
Domachowske JB; Bonville CA; Dyer KD; Rosenberg HF
Nucleic Acids Res; 1998 Dec; 26(23):5327-32. PubMed ID: 9826755
[TBL] [Abstract][Full Text] [Related]
15. Rapid evolution of a unique family of primate ribonuclease genes.
Rosenberg HF; Dyer KD; Tiffany HL; Gonzalez M
Nat Genet; 1995 Jun; 10(2):219-23. PubMed ID: 7663519
[TBL] [Abstract][Full Text] [Related]
16. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
Slifman NR; Loegering DA; McKean DJ; Gleich GJ
J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
[TBL] [Abstract][Full Text] [Related]
17. Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides.
Pulido D; Prats-Ejarque G; Villalba C; Albacar M; Moussaoui M; Andreu D; Volkmer R; Torrent M; Boix E
Eur J Med Chem; 2018 May; 152():590-599. PubMed ID: 29763807
[TBL] [Abstract][Full Text] [Related]
18. Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction.
Suzuki M; Saxena SK; Boix E; Prill RJ; Vasandani VM; Ladner JE; Sung C; Youle RJ
Nat Biotechnol; 1999 Mar; 17(3):265-70. PubMed ID: 10096294
[TBL] [Abstract][Full Text] [Related]
19. A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities.
Pulido D; Prats-Ejarque G; Villalba C; Albacar M; González-López JJ; Torrent M; Moussaoui M; Boix E
Antimicrob Agents Chemother; 2016 Oct; 60(10):6313-25. PubMed ID: 27527084
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the membrane interaction mechanism of two antimicrobial RNases: RNase 3/ECP and RNase 7.
Torrent M; Sánchez D; Buzón V; Nogués MV; Cladera J; Boix E
Biochim Biophys Acta; 2009 May; 1788(5):1116-25. PubMed ID: 19366593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
